17 completed, 3 active not recruiting, 3 unknown, 2 recruiting. 29 Phase 3, 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 29 | Completed 17, Active not recruiting 3, Unknown 3, Recruiting 2, Terminated 2, Withdrawn 2 |
| Phase 2 | 4 | Completed 2, Withdrawn 2 |
Follow Medication Adherence: new trials by email Literature Review of Medication Adherence trials Research Report on Medication Adherence
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluation of a Disability-Focused Sexual and Reproductive Health Curriculum for Health Students in Tanzania Disability-Focused Sexual and Reproductive Health Curriculum - Sexual and Reproductive Health, Disability | Phase 3 | Active not recruiting | University of Minnesota | 412 | 2026-09-01 | 2026-09-17 |
| Stroke Minimization Through Additive Anti-atherosclerotic Agents in Routine Treatment II Study (SMAART II) Polycap - Stroke, Medication Adherence | Phase 3 | Recruiting | Northern California Institute of Research and Education | 1000 | 2026-04-01 | 2026-07-06 |
| Testing a Real-time Electronic Antiretroviral Adherence Monitoring Intervention A-TEAM - HIV Infections, Adherence, Medication | Phase 3 | Active not recruiting | University of Illinois at Chicago | 126 | 2024-10-01 | 2026-08-17 |
| Outcomes of the PLHIV With Suboptimal Viral Suppression to Injectable Long-acting Antiretrovirals cabotegravir/rilpivirine (600mg/ 900mg), Antiretroviral Combinations - HIV-1-infection, Non-Adherence, Medication | Phase 3 | Active not recruiting | Chang Gung Memorial Hospital | 40 | 2024-07-19 | 2026-10-26 |
| Next Generation Ingestible Sensors for Medication Adherence Measurement Next-generation Reader and ID-Cap System, Truvada for pre-exposure prophylaxis (PrEP), Biktarvy for antiretroviral therapy (ART) - HIV Infection, Adherence, Medication | Phase 3 | Completed | Brigham and Women's Hospital | 15 | 2023-02-06 | 2024-09-25 |
| SmartSteps: A Context-Aware, PrEP Adherence Intervention for Individuals With Substance Use Disorder Descovy or Truvada, ID-Cap System, Beiwe - HIV Infections, Substance Use | Phase 3 | Completed | Brigham and Women's Hospital | 40 | 2022-12-20 | 2026-07-21 |
| Motivational Enhancement Therapy to Improve Adherence to Aromatase Inhibitors Motivational enhancement therapy, Attention Control - Breast Cancer, Medication Adherence | Phase 2 / Phase 3 | Withdrawn | University of Calgary | 2020-08-01 | 2024-12-05 | |
| Reducing the Burden of Chronic Psychotic Disorders in Tanzania (CAPACITY) Customized Adherence Enhancement, Haloperidol Decanoate - Schizophrenia, Medication Nonadherence | Phase 3 | Completed | Case Western Reserve University | 22 | 2019-11-05 | 2021-10-12 |
| Role of Pegylated Interferon in Combination With DAAs to Cure Hepatitis C As Soon As Possible - Hepatitis C [ASAP-C] Sofosbuvir, Daclatasvir, Pegylated Interferon alfa-2a - Hepatitis C, Chronic | Phase 2 / Phase 3 | Completed | Johns Hopkins Bloomberg School of Public Health | 150 | 2018-02-02 | 2021-05-18 |
| Incidence of Non Adherence to Treatment With Once-daily Formulation of Tacrolimus Tacrolimus BID, Advagraf QD - Medication Adherence | Phase 3 | Unknown | Rabin Medical Center | 60 | 2016-08-01 | 2016-07-12 |
| Cytoreductive Prostatectomy Combined With Triple or Dual Systemic Therapy in mHSPC Patients Cytoreductive prostatectomy or brachytherapy, ADT+second-generation antiandrogens ± chemotherapy - Metastatic Prostate Cancer, Therapy, Directly Observed | Phase 3 | Recruiting | The First Affiliated Hospital with Nanjing Medical University | 200 | 2016-01-01 | 2024-04-05 |
| SystemCHANGE: An Intervention for Medication Change in Adult Kidney Transplant Patients SystemCHANGE, Patient-education attention control - Kidney Disease | Phase 3 | Unknown | Cynthia Russell | 84 | 2014-06-01 | 2018-05-04 |
| Prograf-Advagraf Cross Over Conversion Study Tacrolimus - Kidney-Pancreas Transplantation | Phase 3 | Completed | University Health Network, Toronto | 13 | 2013-06-01 | 2014-09-18 |
| Technology Enhanced Nurse Navigator Trial (TENN Trial) Interactive navigational support, Internet access - Medication Adherence | Phase 3 | Completed | Mercy Medical Center | 101 | 2012-02-01 | 2015-04-17 |
| The REPOSE (Relative Effectiveness of Pumps Over MDI and Structured Education) Trial CSII (Insulin Pump) plus DAFNE, MDI (levemir® & quick acting insulin) plus DAFNE - Type 1 Diabetes | Phase 3 | Completed | Sheffield Teaching Hospitals NHS Foundation Trust | 267 | 2011-11-01 | 2021-01-26 |
| Reducing Heavy Drinking to Optimize HIV/AIDS Treatment and Prevention Naltrexone, Placebo + Medication Management/Medication Coaching - Reduction in Heavy Drinking in Patients With HIV | Phase 2 / Phase 3 | Completed | Yale University | 51 | 2011-04-01 | 2019-03-21 |
| Testing Counseling Styles to Motivate Smokers to Quit Brief Advice (BA), Motivational Interviewing (MI), Health Education (HE) - Smoking, Tobacco Use | Phase 3 | Completed | University of Missouri, Kansas City | 255 | 2010-10-01 | 2012-07-04 |
| Practice-based Trial of Blood Pressure Control in African Americans Therapeutic Lifestyle Changes (MINT-TLC), Usual Care - Hypertension, Physical Activity | Phase 3 | Completed | NYU Langone Health | 194 | 2010-02-01 | 2013-11-13 |
| Using IVR to Maintain ACS Patients on Best Practice Guidelines IVR group - Acute Coronary Syndrome, Medication Adherence | Phase 3 | Terminated | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 654 | 2010-01-01 | 2017-08-28 |
| Milestones of Adjustment Post-Psychosis Training in all modules including MAPP Recovery Model, Training in all modules except MAPP Recovery Model - Schizophrenia, Quality of Life | Phase 3 | Terminated | Yale University | 110 | 2009-11-01 | 2016-09-08 |
Showing 20 of 29. Sign in to see all of them.
Health Education (6) · HIV Infections (5) · Diabetes Mellitus (3) · Directly Observed Therapy (3) · Psychotic Disorders (3) · Treatment Adherence and Compliance (3) · Behavior (2) · Colitis, Ulcerative (2) · Hypertension (2) · Schizophrenia (2) · Substance-Related Disorders (2) · Acute Coronary Syndrome (1) · Adherence Interventions (1) · Alcoholism (1)
Health Behavior (29) · Patient Acceptance of Health Care (28) · Patient Compliance (28) · Behavior (27) · Treatment Adherence and Compliance (26) · Mental Disorders (7) · Urogenital Diseases (7) · Adherence Interventions (6) · Blood-Borne Infections (6) · Communicable Diseases (6) · Genital Diseases (6) · Immune System Diseases (6) · Infections (6) · RNA Virus Infections (6)
Motivational Interviewing (3) · Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination (2) · Tacrolimus (2) · Brachytherapy (1) · Crisis Intervention (1) · Drug Delivery Systems (1) · Drug Therapy (1) · Haloperidol (1) · Insulin Detemir (1) · Mesalamine (1) · Naltrexone (1) · Pre-Exposure Prophylaxis (1) · Rilpivirine (1) · Ritonavir (1) · Saquinavir (1)
Brigham and Women's Hospital (3) · University Health Network, Toronto (2) · Yale University (2) · Case Western Reserve University (1) · Centers for Disease Control and Prevention (1) · Chang Gung Memorial Hospital (1) · Cynthia Russell (1) · Henry Ford Health System (1) · Johns Hopkins Bloomberg School of Public Health (1) · London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's (1) · Medical University of South Carolina (1) · Mercy Medical Center (1) · NYU Langone Health (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1) · Northern California Institute of Research and Education (1)
United States (16) · Canada (4) · Tanzania (3) · Benin (1) · China (1) · Ghana (1) · India (1) · Israel (1) · Nigeria (1) · Taiwan (1) · Thailand (1) · United Kingdom (1)
Barbara C Tilley, PhD (1) · Carl Latkin, PhD (1) · Daniel H. Solomon, MD, MPH (1) · Delwyn Catley, Ph.D. (1) · Eyan Mor, MD (1) · Gbenga G Ogedegbe, M.D. (1) · Irene Tessaro, DrPH (1) · Janis Campbell, RN (1) · Jihad Slim, MD (1) · John F Mayberry, DScMD (1) · Kathy Helzlsouer, M.D., M.H.S. (1) · Kristen Mark, PhD,MPH (1) · L. Keoki Williams, MD, MPH (1) · Lixin Hua, M.D. (1)
PMID 36094829, PMID 22192273, PMID 22371876, PMID 22713093, PMID 23362861, PMID 26135553, PMID 26711164, PMID 27081187, PMID 27421884, PMID 28360027, PMID 28440211, PMID 29895280, PMID 31291507, PMID 31466882, PMID 32438024, PMID 33293392, PMID 35086504, PMID 37932493, PMID 40243391, PMID 41727852
DP2DA056107 (1), P60AR047782 (1), R01AA018923 (1), R01CA133068 (1), R01DA026727 (1), R01DK064695 (1), R01HD110999 (1), R21MH114700 (1)